MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
about
MicroRNA in rectal cancerRole of Natural Radiosensitizers and Cancer Cell Radioresistance: An UpdateMicroRNAs in colorectal carcinoma--from pathogenesis to therapyMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerNon-coding landscapes of colorectal cancerPredictive Biomarkers to Chemoradiation in Locally Advanced Rectal CancerAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancerDifferential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsUp-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancerMicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapySerum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancerChanges in circulating microRNAs after radiochemotherapy in head and neck cancer patients.miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.MicroRNAs in colorectal cancer as markers and targets: Recent advances.Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma.Cancer biomarker discovery: current status and future perspectives.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Genetic and epigenetic markers in colorectal cancer screening: recent advances.MicroRNA-190b confers radio-sensitivity through negative regulation of Bcl-2 in gastric cancer cells.Noncoding RNA and colorectal cancer: its epigenetic role.microRNAs and Colorectal Cancer.Molecular Diagnostic Applications in Colorectal Cancer.MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal CancerSerum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
P2860
Q26748754-7F3CB148-88C1-4816-93A9-DC5BD162D0D8Q26753100-C4B6AF46-5D58-4DFF-BB1E-FB3996EDC43EQ26766510-D096AB0D-37CE-4285-8F5E-B282BE291E6CQ26775610-529BC6B9-9F75-47AA-8F14-075F9603DA4CQ26778014-B9BFFE30-800F-45CB-94ED-C07124E037AAQ26778557-0BA2592C-79EE-433C-9E82-0932359FC8DBQ27024427-8001A573-4E75-49AF-BD10-5D3FF5393E5CQ28066481-605B5C04-384C-475B-BF3A-ACF98865761EQ33829311-ACAB84A6-E104-4354-A365-1306C8094915Q34036131-8D0A9EB8-2B1E-4BB3-830B-93B53403956FQ34343614-D09484DA-C0EE-43D2-AF32-B49C66E6BE50Q34787505-EE0B1394-4BDB-449D-8BB9-AB4E36CAFFC7Q35107341-DED4C8A7-F980-45DD-9F22-F8A8159BD37BQ35682549-3C2C1857-20E9-4233-B4C0-9A1B04825998Q35919161-0AFCF0C9-7158-4663-A349-19CBE150E3D3Q35944089-A6753413-65E8-4122-B736-C530C356A0E3Q36847230-1C13A1CD-AFC8-4ABF-8332-5293913196FDQ36900550-49213078-F480-4134-B913-FB7C2E788F5DQ37106318-E51C8725-2760-4E89-A3FB-BD704AB0C8B5Q37317631-DF7248B4-CCC1-4AB9-B658-D3333D8E853DQ37349506-0C4D0328-4DFF-44DC-8C31-81BDDC26C4A7Q37438786-D8E25564-CC5E-46E6-ABEB-32B621340D1FQ37641603-20847E17-DEE8-4DD1-ABE1-451BB82F2452Q37665639-CC35D9D3-9521-4F2D-8F1D-27EEA0DF432EQ37708024-418B4A85-EC33-4A50-9B86-2F08C528B7BFQ37709253-8E0C528B-074F-4968-B8ED-AF75777951F4Q37721653-2996B7E7-CB60-4DE4-9D51-8CE76F65D947Q38187679-FE992980-3098-42F8-BA04-A37B5E6DF427Q38202662-168F2D69-9179-4199-9536-87E0FC639025Q38435405-9D6D4282-CE19-4995-89EC-93B05BBB926AQ38552402-43B68555-C866-4EEE-A1D5-593EB8E1BE65Q38594617-A0E87C54-5CD3-4C1E-9CC4-822E7C1351A4Q38676702-53BAED8C-2D09-4583-B222-B18DC04D0434Q38723197-92CEDFBC-35AB-4FE6-AD85-02DCC47F3492Q38859581-B967021A-D85E-4981-8894-740441CEAE8EQ38932823-7B66CF6D-547C-469A-95AE-B4BA90B8D4D1Q38947671-12123E43-6A11-4388-B7BB-CF47E627FD57Q39390383-184DF201-F34E-4B03-ACD3-4957293814C6Q40714376-2C0AD24D-1584-4C41-A164-47AEFA521F13Q43054579-00C94239-96E4-46A8-83EE-1FAD80C341C7
P2860
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MicroRNA expression profile as ...... vanced rectal cancer patients.
@ast
MicroRNA expression profile as ...... vanced rectal cancer patients.
@en
type
label
MicroRNA expression profile as ...... vanced rectal cancer patients.
@ast
MicroRNA expression profile as ...... vanced rectal cancer patients.
@en
prefLabel
MicroRNA expression profile as ...... vanced rectal cancer patients.
@ast
MicroRNA expression profile as ...... vanced rectal cancer patients.
@en
P2093
P2860
P356
P1433
P1476
MicroRNA expression profile as ...... vanced rectal cancer patients.
@en
P2093
Ilona Kocakova
Jana Gombosova
Jana Nekvindova
Lenka Radova
Marek Svoboda
Ondrej Slaby
Pavel Fabian
Rostislav Vyzula
P2860
P2888
P356
10.1186/1748-717X-7-195
P577
2012-11-20T00:00:00Z
P5875
P6179
1018960343